(UroToday.com) In an interactive session of the American Society for Radiation Oncology (ASTRO) Annual Congress focussing on the management of patients with Intermediate Risk Prostate Cancer from initial consultation through treatment to follow-up, Dr. Neil Desai presented on the conundrum that is intermediate prostate cancer: while we have a wealth of choices, this can make treatment decision making difficult.